Cholesterol reduction in the prevention of coronary heart disease: therapeutic rationale and guidelines. The British Hyperlipidaemia Association.
作者信息
Cobbe S M, Shepherd J
机构信息
Department of Medical Cardiology, Royal Infirmary, Glasgow.
出版信息
Br Heart J. 1993 Jan;69(1 Suppl):S63-9. doi: 10.1136/hrt.69.1_suppl.s63.
Abstract
摘要
相似文献
1
Cholesterol reduction in the prevention of coronary heart disease: therapeutic rationale and guidelines. The British Hyperlipidaemia Association.降低胆固醇预防冠心病：治疗原理与指南。英国高脂血症协会。
Br Heart J. 1993 Jan;69(1 Suppl):S63-9. doi: 10.1136/hrt.69.1_suppl.s63.
2
Management of hyperlipidaemia after coronary revascularisation: follow up study.冠状动脉血运重建术后高脂血症的管理：随访研究
BMJ. 1998 May 16;316(7143):1499. doi: 10.1136/bmj.316.7143.1499.
3
4
After the meta-analyses: a commentary on treatment of dyslipidaemia in the primary prevention of coronary heart disease.
Aust N Z J Med. 1994 Dec;24(6):717-21. doi: 10.1111/j.1445-5994.1994.tb01790.x.
5
Therapeutic intervention for hypercholesterolemia.
Clin Cardiol. 1992 Nov;15(11 Suppl 3):III18-21; discussion III22-4.
6
7
[Treatment of high blood cholesterol in patients with coronary heart disease].[冠心病患者高血胆固醇的治疗]
Nihon Rinsho. 2003 Apr;61 Suppl 4:675-81.
8
Lipid-regulating and antiatherosclerotic therapy: current options and future approaches.脂质调节与抗动脉粥样硬化治疗：当前选择与未来方法
Cleve Clin J Med. 1996 Jan-Feb;63(1):31-41. doi: 10.3949/ccjm.63.1.41.
9
Prevention of coronary heart disease through cholesterol reduction.通过降低胆固醇预防冠心病。
Am Fam Physician. 1997 May 1;55(6):2250-8.
10
[Hyperlipidemia in the elderly].[老年人高脂血症]
Nihon Rinsho. 2002 May;60(5):1017-23.
引用本文的文献
1
A case of membranous glomerulonephritis presenting as pulmonary embolism and acute hyperlipidaemia.一例表现为肺栓塞和急性高脂血症的膜性肾小球肾炎病例。
J Clin Pathol. 2002 Jul;55(7):538-40. doi: 10.1136/jcp.55.7.538.
本文引用的文献
1
Lipolytic enzymes and plasma lipoprotein metabolism.脂解酶与血浆脂蛋白代谢
Annu Rev Biochem. 1980;49:667-93. doi: 10.1146/annurev.bi.49.070180.003315.
2
Blood lipids in middle-aged British men.英国中年男性的血脂情况
Br Heart J. 1983 Mar;49(3):205-13. doi: 10.1136/hrt.49.3.205.
3
Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin.冠心病药物研究项目患者的15年死亡率：烟酸的长期益处
J Am Coll Cardiol. 1986 Dec;8(6):1245-55. doi: 10.1016/s0735-1097(86)80293-5.
4
Reducing cholesterol does not reduce mortality.降低胆固醇并不能降低死亡率。
J Am Coll Cardiol. 1988 Sep;12(3):814-7. doi: 10.1016/0735-1097(88)90327-0.
5
Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.赫尔辛基心脏研究：吉非贝齐用于中年血脂异常男性的一级预防试验。治疗安全性、危险因素变化及冠心病发病率
N Engl J Med. 1987 Nov 12;317(20):1237-45. doi: 10.1056/NEJM198711123172001.
6
Strategies for reducing coronary heart disease and desirable limits for blood lipid concentrations: guidelines of the British Hyperlipidaemia Association.降低冠心病的策略及血脂浓度的理想限值：英国高脂血症协会指南
Br Med J (Clin Res Ed). 1987 Nov 14;295(6608):1245-6. doi: 10.1136/bmj.295.6608.1245.
7
How-often-that-high graphs of serum cholesterol. Findings from the Scottish Heart Health and Scottish MONICA studies.血清胆固醇水平过高的情况有多常见。来自苏格兰心脏健康研究和苏格兰MONICA研究的结果。
Lancet. 1989 Mar 11;1(8637):540-2. doi: 10.1016/s0140-6736(89)90077-9.
8
Deaths due to accidents and violence in two recent trials of cholesterol-lowering drugs.在最近两项降胆固醇药物试验中因意外和暴力导致的死亡情况。
Arch Intern Med. 1990 Oct;150(10):2169-72.
9
Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations.低胆固醇浓度人群的血清胆固醇浓度与冠心病
BMJ. 1991 Aug 3;303(6797):276-82. doi: 10.1136/bmj.303.6797.276.
10
Effectiveness of low-dose colestipol therapy in patients with moderate hypercholesterolemia.小剂量考来烯胺治疗中度高胆固醇血症患者的疗效
Am J Cardiol. 1992 Jul 15;70(2):135-40. doi: 10.1016/0002-9149(92)91264-5.
Zotero 插件